Trademark: 97198814
Status Date
Tuesday, April 9, 2024
Registration Number
7356212
Registration Date
Tuesday, April 9, 2024
Filing Date
Friday, December 31, 2021
Published for Opposition
Tuesday, November 8, 2022
42 Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease, metabolic diseases; Providing medical and scientific research information, consultancy, and advisory services in the fields of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease; Compiling data for medical and scientific research, clinical trials, and drug admission
The mark consists of four stylized Chinese characters that transliterate to "Xi Li Ke Ji".
Color is not claimed as a feature of the mark.
The non-Latin characters in the mark transliterate to xi li ke ji and this means Creek Gravel Science Technology in English.
THE CHINESE CHARACTERS THAT TRANSLITERATE TO "KE JI"
Apr 9, 2024
Registered-Principal Register
Apr 9, 2024
Notice Of Registration Confirmation Emailed
Apr 9, 2024
Notice Of Registration Confirmation Emailed
Mar 6, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 5, 2024
Allowed Principal Register - Sou Accepted
Feb 28, 2024
Teas/Email Correspondence Entered
Feb 28, 2024
Correspondence Received In Law Office
Feb 28, 2024
Assigned To Lie
Oct 6, 2023
Teas Response To Office Action Received
Jul 28, 2023
Notification Of Non-Final Action E-Mailed
Jul 28, 2023
Non-Final Action E-Mailed
Jul 28, 2023
Su - Non-Final Action - Written
Jul 14, 2023
Statement Of Use Processing Complete
Jun 15, 2023
Use Amendment Filed
Jul 12, 2023
Case Assigned To Intent To Use Paralegal
Jun 15, 2023
Teas Statement Of Use Received
Jan 3, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Published For Opposition
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Oct 6, 2022
Approved For Pub - Principal Register
Oct 6, 2022
Examiner's Amendment Entered
Oct 6, 2022
Notification Of Examiners Amendment E-Mailed
Oct 6, 2022
Examiners Amendment E-Mailed
Oct 6, 2022
Examiners Amendment -Written
Oct 4, 2022
Assigned To Examiner
Sep 1, 2022
Teas Change Of Correspondence Received
Sep 1, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 7, 2022
Notice Of Design Search Code E-Mailed
Jan 6, 2022
New Application Office Supplied Data Entered
Jan 4, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
